摘要
术前深度单采自体红细胞和/或血小板储血技术(简称:深度单采自体储血技术)是储存式自体输血的一种新型方式,近年来该技术在国内多家医院相继开展,但其实施过程与质量控制方面尚未形成共识或技术操作规范。为此,中国输血协会临床输血管理学专业委员会组织全国相关领域专家,对术前深度单采自体储血技术的技术原理、准入要求、适应证、禁忌证、操作要点、不良反应防治、采集血液质量评价及处置等方面广泛深入探讨后,共同制定本共识。旨在更好地进行患者自体血液管理,同时为医护人员更加安全、规范地实施术前深度单采自体储血技术工作提供依据。
Preoperative Advanced Autologous Apheresis(AAA)is a new type of preoperative autologous blood donation.In recent years,this technology has been introduced in many hospitals across the country.However,there has yet to be a consensus or technical standard for its implementation process and quality control.To address this,the Chinese Blood Transfusion Association Clinical Transfusion Management Committee organized experts from related fields nationwide to extensively and deeply discuss the technical principles,entry requirements,indications,contraindications,operational key points,adverse reaction prevention and treatment,and blood quality evaluation and disposition of preoperative Advanced Autologous Apheresis,and jointly formulated this consensus.The aim is to better manage autologous blood for patients and to provide a basis for medical staff to implement preoperative Advanced Autologous Apheresis more safely and standardized.
出处
《临床输血与检验》
CAS
2024年第2期145-155,共11页
Journal of Clinical Transfusion and Laboratory Medicine
关键词
术前自体储血
单采自体红细胞
单采自体血小板
质量控制
专家共识
Preoperative autologous blood donation
Autologous erythrocyte apheresis
Autologous platelet apheresis
Quality control
Expert consensus
作者简介
陈冠伊,主要从事术前深度单采自体储血技术研究,(E-mail)yiyi037118@sina.com;查占山,主要从事输血管理与输血治疗研究,(E-mail)chazhanshan@163.com;通信作者:欧阳锡林,国防科技创新特区重点项目首席专家,主要从事术前深度单采自体储血技术和围术期血液管理,(E-mail)ouy70304@163.com;共同通信作者:李志强,主要从事血液病学诊治与输血医学研究,(E-mail)kcb039@126.com。
